Clinical Trial

Phase I/III Clinical Trial of Adsorbed Tetanus Vaccine

Name: Phase I/III Clinical Trial of Adsorbed Tetanus Vaccine — clinical trial record (NCT07740733)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 3

View on ClinicalTrials.gov →

Summary

The study aimed to evaluate the safety and immunogenicity of an adsorbed tetanus vaccine in healthy individuals between 18 and 43 years of age.

Trial Details

NCT Number	NCT07740733
Lead Sponsor	Beijing Minhai Biotechnology Co., Ltd
Conditions	Tetanus, Tetanus Vaccine
Enrollment	1,240 participants
Start Date	2024-02-29
Primary Completion	2024-12-23 (estimated)
Study Completion	2024-12-23 (estimated)
Updated on ClinicalTrials.gov	2026-08-03